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Previous studies have noted the existenice of a 190,000-daltoin vesicular stoma-
titis virus (VSV) protein called the large (L) protein. To determine whether this
protein is a nonspecific aggregate, a precursor to the other VSV proteins, or a unique
viral protein, its synthesis relative to the other VSV proteins was studied under
conditions of inhibition of initiation of protein synthesis. Also, its tryptic peptides
were compared to those of the other VSV proteins. In both cases the results were
consistent with the identification of the large protein as a unique viral protein.
Polyacrylamide gel electrophoresis has resolved
five proteins which are present in virions of
vesicular stomatitis virus (VSV) and are synthe-
sized in VSV-infected cells (2, 10, 14, 23). These
proteins have been designated the M, NS, N, G,
and L proteins with estimated molecular weights
of 29,000, 45,500, 50,000, 69,000, and 190,000, re-
spectively (21). The three major VSV structural
proteins are the M (matrix), N (nucleocapsid),
and G (glycoprotein). The function of the NS and
L (large) proteins is presently unknown, but one or
both of them have been implicated as components
of the virion-associated transcriptase (4).
Although there is general agreement that the
M, NS, N, and G proteins are distinct poly-
peptides, it has been suggested that the L protein
might be an aggregate of the other viral pro-
teins (14, 23). The L protein is found only in
small amounts in both the cytoplasin and the
virion, but this one protein would require about
50% of the coding capacity of the VSV genome
to specify its structure. Attempts to dissociate
the L protein in 8 M urea have not been suc-
cessful (22). To determine whether the L pro-
tein is an aggregate, a precursor of the other VSV
proteins, or a unique viral protein, two experi-
mental approaches have beeii employed in the
l)resellt study. (i) VSV l)rotein synthesis was
studied in the presence of low concentratioiis of
pactamycin, a drug which inhibits initiation of
protein synthesis but lermits continued trans-
lation once initiation has occurred. Under these
circumstances, proteins translated from large
mRNA molecules should continue to be syn-
thesized after the time that translation directed
by the smaller mRNA has ceased. Therefore, if
the L protein is translated from a larger mRNA,
addition of pactamycin should cause an increase
in the amount of L protein synthesized relative
to the synthesis of all of the other VSV proteins,
but there should be no increase if the L protein
is an aggregate. (ii) The tryptic peptides of the
L protein were compared to those of all the
other VSV proteins. If the L protein is an ag-
gregate or a precursor of all the other VSV pro-
teinis, then its l)eptide profiles should be identical
to that of the other VSV proteins. If the L pro-
tein is an aggregate of only one or two of the
other VSV l)roteins, then it should contain a
smaller number of peptides, all of which should
correspond to peptides generated by the other
VSV proteins. If the L protein is unique, its
peptide profile should be dissimilar to that of the
other VSV proteins.
MATERIALS AND METHODS
Infection of cells. The growth of VSV in Chi-
nese hamster ovary (CHO) cells has been de-
scribed previously (5, 17, 18).
Incorporation of radioactive precursor into
virus-specific protein. Cells were harvested
from the growth medium and suspended at 2 X
106/ml in either Earle saline (3) or minimal essen-
tial medium minus lysine. The appropriate amino
acids were then added for the indicated times.
Samples were removed and assayed for radioac-
tivity as previously described (20).
Polyacrylamide gel electrophoresis. Cyto-
plasmic extracts were prepared by disrupting cells
in Nonidet P-40 and removing the nuclei by cen-
trifugation. The extracts were treated as previ-
ously described (20) and subjected to the Maizel
and Laemmli modification of sodium dodecyl
sulfate-polyacrylamide 4el electrophoresis (11, 13)for approximately 3.5 h at 100 V.
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Column chromatography of tryptic pep-
tides. Radioactive VSV proteins were eluted
from polyacrylamide gels by shaking overnight
with 0.1% sodium dodecyl sulfate, reduced by re-
action with 12 mg of dithiothreitol for 60 min at
37 C, and then alkylated by incubation with 40
mg of iodoacetamide for 1 h at 4 C. The protein
was precipitated with 15% trichloroacetic acid,
washed with 5% trichloroacetic acid, and lyophil-
ized. The precipitate was then dissolved in 1 ml of
0.1M ammonium bicarbonate, pH 8.0, lyophilized,
and suspended in 1 ml of ammonium bicarbonate
and 50 pg of trypsin. After 12 to 16 h at 37 C, an
additional 50 pg of trypsin was added, and the
solution was incubated for a further 4-h period.
The digest was then lyophilized, dissolved in 1 ml
of 0.2 M pyridine-acetate buffer, pH 3.1, lyophil-
ized, and suspended in the pyridine-acetate buffer.
The sample was applied to a 55- by 0.9-cm column
of Technicon type P chromobeads ion exchange
resin maintained at 50 C and eluted as previously
described (8). Fractions of about 1.5 ml were
added to 20-ml cocktail D (1) and counted in a
Beckman LS-250 scintillation counter.
Materials. 3H-L-leucine at 39 Ci/mmol, '4C-L-
leucine at 261 mCi/mmol, 3H-L-lysine at 26.8
Ci/mmol or 2 Ci/mmol, and 14C-L-lysine at 312
mCi/mmol were purchased from New England
Nuclear Corp., Boston, Mass. Pactamycin was a
kind gift of the Upjohn Company; act'inomycin D
was a kind gift of Merck, Sharpe, and Dbhme.
RESULTS
Polyacrylamide gel electrophoresis of
VSV cytoplasmic and vfrion proteins. A
mixture of a cytoplasmic extract of VSV-infected
CHO cells labeled with 'H-lysine with a prepa-
ration of virion proteins labeled with 14C-leucine
was analyzed by electrophoresis oi 5%, 7.2%,
and 10% polyacrylamide gels (Fig. 1). In 5%
gels, the large L protein was clearly resolved,
whereas the smaller VSV proteins migrated
together with the dye marker. Electrophoresis
through 7.2% gels resolved the L, G, NS, and
N proteins, but the M protein still migrated with
the front. In previous reports (10, 13, 21) the NS
protein was found to migrate slightly faster
than the N protein; we have seen no such pro-
tein but have seen a peak of the expected size
migrating -more slowly than the N protein.
This peak, migrating slower than the N protein,
is apparently the same as the one seen in other
studies because it represents a much larger pro-
portion of cytoplasmic protein than it does of
virion protein. Its migration relative to the N
protein is apparently a function of the conditions
of gel electrophoresis. When we used the elec-
trophoresis system employed in other studies,
we could confirm that the NS protein migrated
more rapidly than the N protein, but, in the
Laemmli-Maizel gel system, which we have used
in the present studies, it migrated more slowly
than the N protein. In agreement with previous
reports, the G protein isolated from the virion
migrated more slowly than the cytoplasmic G
protein (10). The 10% gels resolved the M pro-
tein from the dye front but gave poor separation
of the NS and N proteins.
Effect of pactamycin on VSV-specific
protein synthesis. At 5 X 10-v M, pactamycin
will selectively inhibit initiation of protein syn-
thesis in a reticulocyte cell-free system, but it
will also inhibit chain elongation when it is
present at higher concentrations (12). Since ini-
tiation of protein synthesis cannot be directly
assayed in intact VSV-infected CHO cells, the
ability of various concentrations of pactamycin to
produce a delayed but complete stoppage of
VSV-specific protein synthesis was assayed.
Figure 2 shows that a pactamycin concentration
between 2 X 10-f M and 5 X 10-7 M was suffi-
cient to produce total inhibition of protein syn-
thesis within 12 to 16 min after addition of the
drug. This value is similar to that found in
poliovirus-infected HeLa cells, where 10-7 M
pactamycin was the lowest concentration of the
drug which ultimately produced complete inhi-
bition of protein synthesis (20).
To determine if pactamycin could increase the
amount of L protein relative to the other viral
proteinis, cells infected for 3.25 h were exposed
to 4 X 10-7 M pactamycin, and 3H-lysine was
added after 0, 3, or 6 min. All cells were har-
vested 14 min after addition of pactamycin.
Control cells which had not received pactamycin
were also exposed to 'H-lysine for 14 min. Cyto-
plasmic extracts were analyzed on 7.2% poly-
acrylamide gels (Fig. 3). Although 7.2% gels
do not resolve the M protein from the gel front,
this concentration was chosen because it gave
better resolution of the L protein relative to the
background level of radioactivity in that region
of the gel.
The total radioactivity present in the L, G, NS,
and N protein peaks was determined for each gel,
and the percentage of this radioactivity repre-
sented by the L protein was calculated. In the
control cells (Fig. 3a), the L proteins contained
2.8% of the total radioactivity; in cells labeled
for 14 min after addition of pactamycin, 7.5%
(Fig. 3b); in cells labeled 3 to 14 min after addi-
tion of pactamycin, 12.5% (Fig. 3c); and in cells
labeled 6 to 14 min after addition of pactamycin,
9.3% (Fig. 3d). The percentage of the total
radioactivity present in the G, NS, or N pro-
5r-21VOL. 11,t 1973
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FIG. 1. Polyacrylamide gel electrophoresis of VSV cytoplasmic and virion proteins. "4C-virion proteins
were obtained by infecting CHO cells at an input multiplicity of 10 plaque-forming units per cell and labeling
cells from 1.86 to 4 h postinfection with 6 pCi of "4C-L-leucine per ml in leucine-free minimal essential me-
dium. The released viral particles were harvested at 9 h postinfection, and the purified virus was disrupted in
1% sodium dodecyl sulfate. 3H-cytoplasmic proteins were obtained by infecting cells at an input multiplicity
of 10 plaque-forming units per cell and labeling the cells for 14 min at 8.25 h postinfection with 150 ,Ci of3H-lysine per ml at 2 Ci/mmol. Electrophoresis was as described in Materials and Methods. The fronts were
in fractions 127 to 128 for the 5% gel, fractions 119 to 121 for the 7.2% gel, and fractions 109 to 110 for the10%o gel.
teins remained approximately constant in the of pactamycin. Therefore, in the presence of
various samples. Similar experiments have shown pactamycin, the amount of L protein synthesized
that the percentage of total radioactivity present relative to all of the other viral proteins can be
in the M protein does not increase after addition increased at least fourfold.
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VSV-infected CHO cells at different concentrations
of pactamycin. CHO cells were infected with VSV at
an input multiplicity of 10 plaque-forming units per
cell. At 3 h postinfection, cells were harvested and
suspended in Earle saline at 2 X 106 cells/ml. The
cells were 8eparated into four equal portions, and
pactamycin was added at concentrations of
5 X 107M, 2 X 107 M, 5 X 108 M, or no drug was
added to each. 'H-L-leucine was added to a final con-
centration of 10 ;&Ci/ml simultaneously with the
pactamycin. Samples were taken at the indicated
times and assayed for acid-insoluble radioactivity as
described (19).
Comparison of the tryptic peptides of the
L protein and the other VSV proteins. Cyto-
plasmic extracts of VSV-infected cells labeled
2.75 to 4 h postinfection with 'H-lysine or 14(C
lysine were subjected to electrophoresis on 5,
7.2, and 10% polyacrylamide gels. The relative
proportions of the five VSV proteins were similar
to those shown in Fig. 1 except for a decrease in
the relative amounit of the M proteini, possibly
due to the longer labeling period. The approxi-
mate molar ratios of the G, NS, N, and M
proteins were calculated to be 1:1:2:1 in the
preparation. As also seen in Fig. 1, there were
no detectable cellular protein peaks.
Those fractions from a 5% gel containing the
L protein and those containing all of the other
VSV proteins were prepared for analysis of
their tryptic peptides. Figure 4 shows a compari-
son of the tryptic peptides of "4C-lysine-labeled L
protein and 8H-lysine-labeled M, N, NS, and G
proteins. A similar result was obtained when the
radioactive labels were reversed. Approximately
23 tryptic peptides were generated by the L pro-
tein and about 30 by the other VSV proteins.
The two profiles were grossly dissimilar, although
a few L protein peptides did chromatograph with
peptides present in the other VSV proteins.
DISCUSSION
The experiments reported here argue that the
L protein is indeed a unique VSV-specified pro-
tein. Since most of the L protein tryptic pep-
tides differ from those of the other VSV pro-
teins, it camiot be a precursor or an aggregate
of all of the other VSV proteins. At least 23
tryptic peptides are generated by the L protein
so it is unlikely to be an aggregate of just one
of the smaller VSV proteins because they gen-
erate together a total of about 30 tryptic peptides.
The fourfold enhancement of L protein synthesis
by pactamycin relative to that of each of the
other VSV proteins also argues that the L pro-
tein is not an aggregate of the smaller VSV pro-
teins but is translated from a larger mRNA.
We cannot rule out, however, that there exist some
overlaps between the RNA sequences translated
from the L protein mRNA and the mRNA species
for the other VSV proteins since 5 to 6 of their
tryptic peptides were not resolved.
The VSV proteins are translated from mRNA
species which have a base sequence comple-
mentary to that of the virion RNA (5). These
mRNA species are transcribed by a virion-
associated, RNA-dependent RNA polymerase
(1, 6) and consist of at least three species which
sediment together at about 13 to 15S but separate
on polyacrylamide gels and one species which
sediments at 28S (5). The molecular weights of
the 13 to 15S RNA species are consistent with
their acting as monocistronic mRNAs for the
synthesis of the M, NS, N, and G proteins (16;
Stampfer et al., manuscript in preparation).
The estimated molecular weight of the 28a
mRNA species (2.6 x 106, unpublished observa-
tions) is more than sufficient to code for a protein
of 190,000 daltonis. Therefore, although it may
seem unusual for a virus to use 50% of its codiLng
capacity for the synithesis of one large protein,
the existence of the L protein is entirely con-
sistent with the known properties of VSV
mRNAs. In addition, the L, G, N, NS, and M
proteins have a combined molecular weight of
approximately 380,000, which is within the
coding capacity of the VSV genome which is
approximately 3.6 X 106 to 4.0 X 106 daltons
(6, 7, 14, 15, 16).
The 28S RNA represents about 30 to 40% of
the virus-specific RNA synthesized in VSV-
infected CHO cells (18), whereas the L protein
represents only about 2 to 3% of VSV-specific
protein. It has also been observed that the 28S
mRNA is present on small polyribosomes and
must therefore have a low concentration of
VoL. 11,1 1973 523
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FIG. 3. Polyacrylamide gel electrophoresis of VSV cytoplasmic proteins synthesized by CHO cells after
addition of pactamycin. CHO cells were infected with VSV at an input multiplicity of 10 plaque-forming
units per cell. At 8.26 h postinfection, cells were harvested and suspended in Earle saline at 2 X 106 cells/ml.
The cells were separated into four equal portions, and pactamycin at a concentration of 4 X 107M was added
to three of the portions. 3H-L-lysine at 2 Ci/mmol at a final concentration of 150 ,uCi/ml was added to each
portion for the indicated times. The cells were harvested, and the cytoplasmic extracts were subjected to elec-
trophoresis on 7.2%/ polyacrylamide gels. a, No drug added, cells labeled for 14 min; b, cells labeled 0 to 14
min after additiot& of pactamycin; c, Cells labeled 8 to 14 min after addition of pactamycin; d, Cells labeled
6 to 14 min after addition of pactamycin.
ribosomes per length of RNA (5). Poliovirus
mRNA, which is comparable in size to the VSV
28S mRNA, is present on much larges polyribo-
somes (19). Since there is a large amount of
28S mRNA present in infected CHO cells, yet
only small amounts of L protein are synthesized
oni small polyribosomes, there must be differential
translation of the various viral messenger RNAs,
presumably determined by the frequency of ini-
-tiation of translation on each mRNA.
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FIG. 4. Tryptic peptides of I4C-L-lysine-labeled VSV L protein compared to the tryptic peptides of 3H-L-
lysine-labeled other VSV proteins. CHO cells were infected with VSV at an input multiplicity of 10 plaque-
forming units per cell. At 2.75 h postinfection, cells were harvested and suspended in minimal essential
medium minus lysine. 3H-lysine at 26.8 Ci/mmol at a final concentration of 100 ;&Ci/ml or '4C-lysine at 10
uCi/ml was added, and the cells were harvested at 4 h postinfection. The cytoplasmic extracts were subjected
to electrophoresis on 5% polyacrylamide gels, sliced into 1-mm fractions, and the proteins were eluted by
shaking overnight in 0.1% sodium dodecyl sulfate. The fractions containing the L protein and those con-
taining the other VSV proteins were pooled and prepared for analysis of their tryptic peptides as described.
The two panels represent the fractions from a single column analysis. Symbols: *, 1IC; 0, 3H.
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